Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...

Abstract: This paper investigates the controllability of Cartesian product networks consisting of smaller factor networks via Cartesian product of graphs, reveals the controllability relationship ...

Abstract: A necessary and sufficient algebraic condition is obtained for the controllability of a composite signed network consisting of two factor networks by Cartesian product, which reveals how the ...

Our writers dig deep into the Strategist’s archives to surface the best things we’ve already written about and recommended in a single category. Read more here. In 2015, Charlotte Cho, the founder of ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. While a trip to Home Goods gives us a serotonin ...

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in Descartes-08-treated participants in Phase 2b trial ...